Curtis Jeptha P, Portnay Edward L, Wang Yongfei, McNamara Robert L, Herrin Jeph, Bradley Elizabeth H, Magid David J, Blaney Martha E, Canto John G, Krumholz Harlan M
Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8088, USA.
J Am Coll Cardiol. 2006 Apr 18;47(8):1544-52. doi: 10.1016/j.jacc.2005.10.077. Epub 2006 Mar 29.
The aim of this study was to determine the use of pre-hospital electrocardiogram (ECG) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing reperfusion therapy, and evaluate the effect of pre-hospital ECG on door-to-reperfusion times.
Although national guidelines recommend the use of pre-hospital ECG, there is limited contemporary information about its current use and effectiveness.
Using data from the National Registry of Myocardial Infarction-4, we studied patients with STEMI or left bundle branch block who received acute reperfusion with either fibrinolytic therapy (n = 35,370) or primary percutaneous coronary intervention (PCI) (n = 21,277) within 6 h of admission. We determined the prevalence of pre-hospital ECG use, evaluated the association between pre-hospital ECG and door-to-reperfusion time, and estimated the incremental reduction in time to reperfusion using hierarchical models to adjust for differences in patient and hospital characteristics.
A pre-hospital ECG was performed in 4.5% of the fibrinolytic therapy cohort and in 8.0% of the PCI cohort. After adjusting for patient and hospital characteristics, the use of pre-hospital ECG was associated with a significantly shorter geometric mean door-to-drug time: 24.6 min (95% confidence interval [CI]: 23.7 to 25.5) vs. 34.7 min (95% CI: 34.2 to 35.3; p < 0.0001), and a significantly shorter geometric mean door-to-balloon time (94.0 min [95% CI: 91.8 to 96.3] vs. 110.3 min [95% CI: 108.7 to 112.0]; p < 0.0001).
The national use of pre-hospital ECG to diagnose and facilitate the treatment of STEMI remains low. When used, however, pre-hospital ECG is associated with a significantly shorter time to reperfusion.
本研究旨在确定院前心电图(ECG)在接受再灌注治疗的ST段抬高型心肌梗死(STEMI)患者中的使用情况,并评估院前心电图对门至再灌注时间的影响。
尽管国家指南推荐使用院前心电图,但关于其当前使用情况和有效性的当代信息有限。
利用国家心肌梗死注册研究-4的数据,我们研究了在入院6小时内接受纤维蛋白溶解疗法(n = 35370)或直接经皮冠状动脉介入治疗(PCI)(n = 21277)进行急性再灌注的STEMI或左束支传导阻滞患者。我们确定了院前心电图的使用患病率,评估了院前心电图与门至再灌注时间之间的关联,并使用分层模型估计再灌注时间的增量减少,以调整患者和医院特征的差异。
纤维蛋白溶解疗法队列中有4.5%的患者进行了院前心电图检查,PCI队列中有8.0%的患者进行了院前心电图检查。在调整患者和医院特征后,院前心电图的使用与显著缩短的几何平均门至用药时间相关:24.6分钟(95%置信区间[CI]:23.7至25.5)对比34.7分钟(95%CI:34.2至35.3;p < 0.0001),以及显著缩短的几何平均门至球囊扩张时间(94.0分钟[95%CI:91.8至96.3]对比110.3分钟[95%CI:108.7至112.0];p < 0.0001)。
全国范围内用于诊断和促进STEMI治疗的院前心电图使用率仍然较低。然而,使用院前心电图时,与显著缩短的再灌注时间相关。